CAC Zero: The Strongest "All Clear" in Preventive Cardiology

CAC = 0 5 to 10 year warranty period timeline

A coronary calcium score of zero is the single most powerful negative test result in preventive cardiology. In a 50-year-old with otherwise concerning risk factors, a CAC of zero translates to a 10-year cardiovascular event rate below 1% — lower than the average healthy 35-year-old's risk. The clinical effect of a zero score is so strong that current guidelines specifically allow physicians to downgrade statin or aspirin recommendations in patients whose ASCVD calculator suggests intermediate risk but whose CAC is zero. This page explores what zero actually rules out, what it doesn't, who the rare "zero-CAC heart attack" patients are, and how long the negative test result remains reliable.

What Zero Rules Out
10-Year Event Rate
The "Warranty Period"
Who Still Has Events?
Zero in Younger Adults
Zero in Older Adults
Downgrading Therapy with a Zero Score
When to Re-scan
Research Papers and References
Connections
Featured Videos

What Zero Rules Out

A CAC of zero rules out, with high confidence:

Significant calcified atherosclerotic plaque
Mature atherosclerosis of any duration
The vast majority of clinically silent obstructive coronary disease

What it does not rule out:

Soft (non-calcified) plaque, especially in younger patients early in the atherosclerotic process
Vulnerable plaque (lipid-rich plaque with thin fibrous caps that can rupture without prior calcification)
Coronary artery spasm, dissection, or microvascular dysfunction
Non-atherosclerotic causes of cardiac symptoms (HCM, congenital, electrical)

For most middle-aged and older adults, the calcified component is what dominates risk, so CAC = 0 is highly reassuring. For younger adults with strong family history or markedly elevated Lp(a), a complementary CT coronary angiogram (CCTA) may be appropriate to rule out soft plaque. See the Soft Plaque page.

10-Year Event Rate

The published 10-year cardiovascular event rates with CAC = 0 are remarkable for their consistency across cohorts and decades:

MESA cohort, 10-year CV death/MI — ~1.0% in CAC = 0 patients
Heinz Nixdorf Recall, 10-year CV events — ~1.5% in CAC = 0
CONFIRM registry, 5-year mortality — 0.5% in CAC = 0 (despite the cohort being symptomatic referrals)
Intermediate-risk subgroups — CAC = 0 reduces predicted event rates by 50–70% across most ASCVD risk strata

To put 1% over 10 years in context: that's roughly 0.1% per year, similar to the risk of unintentional injury death in middle-aged adults. Practically speaking, a CAC of zero says: cardiovascular disease is unlikely to be the thing that gets you in the next decade.

The "Warranty Period"

The phrase "warranty period" refers to the duration over which a CAC of zero remains a reliable negative result. Several key observations:

The conversion rate from CAC = 0 to CAC > 0 averages 25–30% over 5 years in middle-aged adults with risk factors
Among those who convert, only a small fraction develop high scores quickly — most go to scores of 1–10 over 5 years
Annual progression slope is faster in patients with diabetes, family history, or untreated dyslipidemia
The clinical event-rate "protection" of CAC = 0 attenuates over 10–15 years — useful, but not permanent

Practical interpretation: a CAC of zero is reliably reassuring for 5–10 years in most patients. After that interval, re-imaging is reasonable, especially in patients with persistent risk factors.

Who Still Has Events?

The 1% who do have events with CAC = 0 cluster into recognizable patterns:

Heavy smokers — smoking accelerates plaque rupture independent of plaque burden
Cocaine users — vasospastic and pro-thrombotic effects
Diabetics with poor glycemic control — despite CAC = 0, microvascular and accelerated soft-plaque disease
Patients with elevated Lp(a) — pro-thrombotic / pro-inflammatory effects on top of any calcium burden
Familial hypercholesterolemia — can have soft plaque early; CAC = 0 less reassuring in young FH patients
Connective tissue disease — lupus, RA accelerate plaque rupture
Acute coronary syndromes from non-atherosclerotic causes — SCAD, vasospasm, cocaine, embolism

These groups warrant additional evaluation despite a CAC = 0. The clinical history matters more than the test result.

Zero in Younger Adults

For an adult under 50 with a CAC of zero:

The absolute reassurance is stronger than at any other age — 10-year event risk well under 0.5%
The warranty may be shorter because there is more time for plaque to develop. Re-scan at 5–7 year intervals if risk factors persist
For very young adults with strong family history (premature CAD before 55 in male first-degree relatives, before 65 in female first-degree relatives) or markedly elevated Lp(a) (>100 nmol/L), CAC = 0 should be supplemented by ApoB and Lp(a) testing, and consideration of CCTA to rule out soft plaque if other risk factors are extreme

Zero in Older Adults

A CAC of zero in someone over 70 is an unusually clean cardiovascular bill of health:

The absolute event rate is exceptionally low — below the median for adults of any age
The warranty is longer in absolute terms because the patient has already passed through the highest-risk decade for atherosclerotic events
Statin therapy in primary prevention can often be deferred or de-escalated
Aspirin use should be reconsidered — the bleeding risk from aspirin tends to outweigh benefit in CAC = 0 elderly
The score is a strong argument against assuming "old age = inevitable cardiovascular disease"

Downgrading Therapy with a Zero Score

The 2018 ACC/AHA cholesterol guideline and subsequent updates explicitly support using CAC = 0 to defer statin therapy in adults at intermediate baseline ASCVD risk who would otherwise meet treatment criteria. The pathway:

Patient has 10-year ASCVD risk between 5% and 19.9% by the pooled cohort equation
Statin recommendation is "consider with risk discussion" — a borderline call
CAC scoring is performed
If CAC = 0, statin can be reasonably deferred and re-evaluation done in 5–10 years
If CAC > 0, statin is initiated; the higher the score, the more aggressive the management

This pathway is one of the strongest practical reasons to obtain a CAC: it can either confirm the need for therapy or justifiably remove the medication conversation for a substantial portion of patients.

When to Re-scan

General intervals for follow-up CAC after an initial zero result:

Low baseline risk, clean lifestyle — re-scan in 7–10 years
Intermediate risk, controlled risk factors — re-scan in 5–7 years
Diabetes, family history, elevated Lp(a) — re-scan in 3–5 years
Onset of new risk factor (new diabetes, sustained hypertension, weight gain) — consider earlier re-imaging
Onset of cardiac symptoms — do not rely on a prior CAC; obtain new evaluation (stress test, CCTA, or troponin as appropriate)

Routine annual or biennial re-imaging is not recommended for CAC = 0 — the calcification process is too slow to track meaningfully on that timeline, and the radiation exposure adds up.

Back to Table of Contents